Latest news with #GenpactLimited
Yahoo
26-05-2025
- Business
- Yahoo
At US$43.51, Is Genpact Limited (NYSE:G) Worth Looking At Closely?
Genpact Limited (NYSE:G), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$54.96 at one point, and dropping to the lows of US$42.04. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Genpact's current trading price of US$43.51 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Genpact's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Good news, investors! Genpact is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 14.42x is currently well-below the industry average of 22.53x, meaning that it is trading at a cheaper price relative to its peers. Although, there may be another chance to buy again in the future. This is because Genpact's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity. View our latest analysis for Genpact Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Genpact's earnings growth are expected to be in the teens in the upcoming years, indicating a solid future ahead. This should lead to robust cash flows, feeding into a higher share value. Are you a shareholder? Since G is currently trading below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive profit outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current price multiple. Are you a potential investor? If you've been keeping an eye on G for a while, now might be the time to enter the stock. Its buoyant future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy G. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision. Since timing is quite important when it comes to individual stock picking, it's worth taking a look at what those latest analysts forecasts are. So feel free to check out our free graph representing analyst forecasts. If you are no longer interested in Genpact, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
09-02-2025
- Business
- Yahoo
Earnings Update: Here's Why Analysts Just Lifted Their Genpact Limited (NYSE:G) Price Target To US$56.33
It's been a pretty great week for Genpact Limited (NYSE:G) shareholders, with its shares surging 13% to US$54.95 in the week since its latest full-year results. It was a credible result overall, with revenues of US$4.8b and statutory earnings per share of US$2.85 both in line with analyst estimates, showing that Genpact is executing in line with expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. View our latest analysis for Genpact Taking into account the latest results, the most recent consensus for Genpact from ten analysts is for revenues of US$5.08b in 2025. If met, it would imply a credible 6.6% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to rise 5.5% to US$3.10. In the lead-up to this report, the analysts had been modelling revenues of US$5.05b and earnings per share (EPS) of US$3.04 in 2025. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates. The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 12% to US$56.33. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Genpact analyst has a price target of US$65.00 per share, while the most pessimistic values it at US$45.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure. These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Genpact's past performance and to peers in the same industry. We can infer from the latest estimates that forecasts expect a continuation of Genpact'shistorical trends, as the 6.6% annualised revenue growth to the end of 2025 is roughly in line with the 6.0% annual growth over the past five years. Juxtapose this against our data, which suggests that other companies (with analyst coverage) in the industry are forecast to see their revenues grow 6.1% per year. It's clear that while Genpact's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself. The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Genpact's earnings potential next year. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving. With that in mind, we wouldn't be too quick to come to a conclusion on Genpact. Long-term earnings power is much more important than next year's profits. We have forecasts for Genpact going out to 2027, and you can see them free on our platform here. That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Genpact , and understanding it should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
30-01-2025
- Business
- Yahoo
Genpact Limited (G) Launches AI Gigafactory to Accelerate Enterprise-Wide AI Adoption and Scaling
We recently compiled a list of the . In this article, we are going to take a look at where Genpact Limited (NYSE:G) stands against the other AI stocks. Technological innovations in steam power, electricity and microprocessors drove the first industrial revolution. Fast forward, artificial intelligence is the catalyst driving the fourth industrial revolution. That's because the technology is reshaping industries at a breakneck speed. From revolutionizing the healthcare sector to addressing cybersecurity challenges to reshaping the auto industry, technology is reshaping the way of life in ways not seen before. According to Markets and Markets, the global AI market is projected to grow at a compound annual growth rate of 35.7% to $1.3 trillion by 2030. Significant advancements in computational power and data availability are the factors expected to accelerate the growth. Similarly, revolutionary technology is giving rise to unique investment opportunities as companies compete against time to develop game-changing innovations and enhance productivity. The $500 billion Stargate project is one such investment that sums up the enormous sums of money that companies are willing to spend to gain an edge on AI. While most of the investments are going to data centers and other infrastructures, companies are also inking deals and partnerships to secure reliable energy to power AI models and infrastructure. The companies that provide the metaphorical picks and shovels of artificial intelligence, the manufacturers of semiconductors, servers, networking gear, and power generators—have seen a sharp increase in stock prices as a result of the spending frenzy. The tremendous opportunity up for grabs is evident due to the blockbuster gains in the equity markets over the past two years. Major US indices are trading near all-time highs. While deep pullbacks have come into play in recent months, Dan Ives at Wedbush Securities remains bullish about the AI-driven rally. Ives dismissed the recent tech stock sell-off caused by DeepSeek as a "tech AI head fake" and believes that investors have a "golden buying opportunity" with it. Ives claims that the fear surrounding the low-cost, high-performance model of the Chinese AI company is exaggerated and won't affect the AI revolution's long-term course. "This DeepSeek tech-driven sell-off will be historically noteworthy in market history," Ives wrote, emphasizing that it does not reflect a genuine threat to AI spending trends. "We expect more innovation in AI and LLM model costs to come down... that is ultimately a great thing for computing power, use cases, and where the tech world is going in this 4th Industrial Revolution." President Donald Trump has already reiterated that DeepSeek is a 'wake-up call' for the U.S. tech industry, insisting the sector should be laser-focused on computing if the US is to maintain its edge on the technology. In an attempt to keep American businesses from lagging behind their Chinese counterparts, Wall Street thinks DeepSeek's success will encourage the US government to increase its investment in AI. 'In the near term, DeepSeek's achievement is likely to pressure the U.S. into increased support for domestic AI development, most likely leading to increased federal investment in AI research and infrastructure,' wrote Mills of Raymond James. The firm added that it could envision the U.S. passing an AI version of the CHIPS and Science Act. For this article, we selected AI stocks by going through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here). A supply chain manager overseeing the delivery of products to a customer after a successful transaction. Number of Hedge Fund Holders: 31 Genpact Limited (NYSE:G) provides business process outsourcing and information technology services. It offers retail customer onboarding, customer service, collections, and card servicing operations. On January 28th, the global advanced technology company unveiled Genpact AI Gigafactory, an AI accelerator designed to scale AI solutions from pilot to full-scale production. Genpact Limited (NYSE:G) AI Gigafactory is the new solution that the company believes will address the growing demand for enterprise-wide AI adoption. Its edge stems from its ability to tackle critical governance challenges. The solution should provide transformative approaches for running businesses, leading to accelerated efficiencies. Genpact AI Gigafactory should revolutionize how enterprises adopt and scale AI solutions quickly and effectively through strategic partnerships with ecosystem partners like Databricks. Overall G ranks 9th on our list of the AI stocks that are shaping up Wall Street. While we acknowledge the growth potential of G as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than G but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap. Disclosure: None. This article was originally published at Insider Monkey. Sign in to access your portfolio
